FDA Adverse Event Injury Summary report: N

NUVASIVE COROENT SYSTEM

MDR report key: 7121741 · Received December 15, 2017

Report

Report Number
2031966-2017-00179
Event Type
Injury
Date Received
December 15, 2017
Date of Event
November 22, 2017
Report Date
December 15, 2017
Manufacturer
NUVASIVE, INC.
Product Code
ODP
PMA / PMN Number
K081611
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

NO PRODUCT WAS RETURNED FOR EVALUATION NOR WERE RADIOGRAPHS PROVIDED TO CONFIRM THE REPORTED EVENT. PRODUCT REMAINS IN-SITU. POTENTIAL ADVERSE EVENTS AND COMPLICATIONS: "...AS WITH ANY MAJOR SURGICAL PROCEDURES, THERE ARE RISKS INVOLVED IN SPINAL/ORTHOPEDIC SURGERY. INFREQUENT OPERATIVE AND POSTOPERATIVE COMPLICATIONS THAT MAY RESULT IN THE NEED FOR ADDITIONAL SURGERIES INCLUDE: DAMAGE TO BLOOD VESSELS..." "...POTENTIAL RISKS IDENTIFIED WITH THE USE OF THIS SYSTEM, WHICH MAY REQUIRE ADDITIONAL SURGERY, INCLUDE: NEUROLOGICAL, VASCULAR OR VISCERAL INJURY..." PRODUCT REMAINS IN-SITU.

Description of Event or Problem · 1

ON (B)(6) 2017, A PATIENT UNDERWENT AN ANTERIOR LUMBAR INTERBODY FUSION PROCEDURE. AFTER PLACING THE ANTERIOR COLUMN REALIGNMENT CAGE, BLEEDING WAS OBSERVED. DOCTOR BELIEVED THE INFERIOR VENA CAVA WAS DAMAGED AND PERFORMED PRESSURE HEMOSTASIS. REPORTEDLY, THE NEXT DAY, BLEEDING STOPPED AND CT IMAGES DID NOT SHOW ANY HEMATOMA(S).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
899842 NUVASIVE COROENT SYSTEM INTERVERTEBRAL BODY FUSION DEVICE ODP NUVASIVE, INC. 6300445P2

Patients

Seq Age Sex Outcome Treatment
1 70 YR Required Intervention